Study #2012-0825
Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for the treatment of Oropharyngeal Cancer of the Head and Neck
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This randomized phase II/III trial studies the side effects and how well intensity-modulated proton beam therapy works and compares it to intensity-modulated photon therapy in treating patients with stage III-IVB oropharyngeal cancer. Radiation therapy uses high-energy x-rays, protons, and other types of radiation to kill tumor cells and shrink tumors. It is not yet known whether intensity-modulated proton beam therapy is more effective than intensity-modulated photon therapy in treating oropharyngeal cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC V7;Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC V7;Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC V7
Study phase:
Phase II/III
Physician name:
Steven Frank
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.